Description of L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, sodium salt(1:?)

Detail of > 15475-56-6

• MSDS Download
• 
• CAS Number:
• 15475-56-6
• Name:

• L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, sodium salt(1:?)

• Formula:
• C20H22 N8 O5 . x Na
• Molecular Structure:
• 
• Synonyms:
• Glutamicacid, N-[p-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, sodiumsalt, L-(+)- (8CI); L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, sodium salt(9CI); Abitrexate; Methotrexate sodium; Methotrexate sodium salt; SodiumL-(+)-methotrexate
• Molecular Weight:
• 476.48
• EINECS:
• 239-495-5
• Density:
• g/cm³
• Boiling Point:
• °Cat760mmHg
• Flash Point:
• °C
• Appearance:
• Orange to yellow crystalline powder
• Safety:
• Poison by intraperitoneal route. An experimental teratogen. Experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits very toxic fumes of Na₂O and NO_x. See also METHOTREXATE.Details